We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) Lithium carbonate extended-release tablets, USP 450mg (Rising)
Section 19A approved medicine
(Approval lapsed) Lithium carbonate extended-release tablets, USP 450mg (Rising)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
QUILONUM SR lithium carbonate 450mg tablet, blister pack - ARTG 53377
Indication(s)
Lithium is indicated in the treatment of acute episodes of mania and hypomania and for the prophylaxis of recurrent manic-depressive illness.
Images
